- WHATS NEW?
- Suppression of chemokines by HDL
- HDL cholesterol linked to oestrogen levels
- New gene loci regulating HDL cholesterol identified
- Abnormal lipids when young predicts atherosclerosis in later life
- JUPITER: Is HDL cholesterol relevant to residual risk in low-risk patients on potent statin therapy?
- EAS Workshop: How does HDL protect against atherosclerosis?
Niacin/laropiprant plus simvastatin shows additive lipid-modifying effects
Extended-release niacin/laropiprant co-administered with simvastatin improved overall lipid control in patients with primary hypercholesterolaemia or mixed dyslipidaemia.
Corporate sponsor
